1-aminocyclohexane derivatives for the treatment of agitation and other behavioural disorders, especially those associated with alzheimer's disease

Details for Australian Patent Application No. 2005219439 (hide)

Owner Merz Pharma GmbH & Co. KgaA

Inventors Ferris, Steven A.; Stoffler, Albrecht; Moebius, Hans-Joerg; Reisberg, Barry; McDonald, Scott

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005219439

PCT Pub. Number WO2005/084655

Priority 60/550,171 03.03.04 US

Filing date 3 March 2005

Wipo publication date 15 September 2005

Acceptance publication date 23 April 2009

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/084655 Priority application(s): WO2005/084655

19 October 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Therapy using 1-aminocyclohexane derivatives for the treatment of behavioural disorders associated with Alzheimer's disease

23 April 2009 Application Accepted

  Published as AU-B-2005219439

20 August 2009 Standard Patent Sealed

30 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005219441-ALK7 and myostatin inhibitors and uses thereof

2005219438-Bicyclic and bridged nitrogen heterocycles